Envestnet Asset Management Inc. Sells 8,905 Shares of Ingredion Incorporated $INGR

Envestnet Asset Management Inc. lowered its stake in Ingredion Incorporated (NYSE:INGR) by 4.4% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 193,709 shares of the company’s stock after selling 8,905 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Ingredion were worth $23,654,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of INGR. Vanguard Group Inc. increased its position in shares of Ingredion by 0.3% during the 2nd quarter. Vanguard Group Inc. now owns 7,266,873 shares of the company’s stock worth $985,533,000 after purchasing an additional 22,487 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Ingredion by 2.2% in the third quarter. Massachusetts Financial Services Co. MA now owns 1,369,448 shares of the company’s stock valued at $167,223,000 after buying an additional 29,433 shares in the last quarter. First Trust Advisors LP increased its holdings in Ingredion by 6.0% during the second quarter. First Trust Advisors LP now owns 982,704 shares of the company’s stock worth $133,274,000 after buying an additional 55,924 shares during the last quarter. Cooke & Bieler LP raised its position in Ingredion by 16.0% during the third quarter. Cooke & Bieler LP now owns 903,346 shares of the company’s stock worth $110,308,000 after acquiring an additional 124,517 shares in the last quarter. Finally, Invesco Ltd. lifted its stake in Ingredion by 2.6% in the second quarter. Invesco Ltd. now owns 876,174 shares of the company’s stock valued at $118,827,000 after acquiring an additional 22,245 shares during the last quarter. 85.27% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Ingredion

In other Ingredion news, CEO James P. Zallie sold 33,597 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $119.66, for a total transaction of $4,020,217.02. Following the sale, the chief executive officer directly owned 50,167 shares in the company, valued at $6,002,983.22. This represents a 40.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Larry Fernandes sold 3,630 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $118.40, for a total transaction of $429,792.00. Following the completion of the transaction, the senior vice president directly owned 32,055 shares in the company, valued at approximately $3,795,312. This represents a 10.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 37,228 shares of company stock worth $4,450,117. 2.30% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Jefferies Financial Group reaffirmed a “hold” rating on shares of Ingredion in a report on Wednesday, February 4th. Wall Street Zen downgraded Ingredion from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Oppenheimer set a $136.00 price objective on Ingredion in a research report on Wednesday, October 22nd. iA Financial set a $124.00 target price on Ingredion in a report on Thursday, November 6th. Finally, Stephens restated an “equal weight” rating and issued a $120.00 price target on shares of Ingredion in a research note on Wednesday, February 4th. One equities research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, Ingredion currently has an average rating of “Hold” and a consensus target price of $125.83.

Ingredion Price Performance

NYSE:INGR opened at $118.34 on Friday. Ingredion Incorporated has a 52 week low of $102.31 and a 52 week high of $141.78. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.73 and a current ratio of 2.66. The firm’s 50-day simple moving average is $113.95 and its 200 day simple moving average is $117.75. The firm has a market cap of $7.52 billion, a price-to-earnings ratio of 10.60, a P/E/G ratio of 0.94 and a beta of 0.71.

Ingredion (NYSE:INGR) last announced its earnings results on Tuesday, February 3rd. The company reported $2.53 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.59 by ($0.06). Ingredion had a return on equity of 17.32% and a net margin of 10.10%.The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.78 billion. During the same quarter in the previous year, the company earned $2.63 EPS. The business’s revenue for the quarter was down 2.4% on a year-over-year basis. Ingredion has set its FY 2026 guidance at 11.000-11.8 EPS. As a group, sell-side analysts predict that Ingredion Incorporated will post 11.14 earnings per share for the current year.

Ingredion Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, January 20th. Stockholders of record on Friday, January 2nd were given a dividend of $0.82 per share. This represents a $3.28 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Friday, January 2nd. Ingredion’s dividend payout ratio is presently 29.39%.

About Ingredion

Ingredion Incorporated is a global ingredient solutions company specializing in the production and sale of starches, sweeteners, nutrition ingredients and biomaterials derived primarily from corn and other plant-based raw materials. The company serves a diverse set of industries, including food and beverage, brewing, pharmaceuticals and personal care, providing functional ingredients that enhance texture, stability, flavor and nutritional value in a wide array of end products.

The company’s product portfolio comprises native and modified starches, high-fructose corn syrup, dextrose, maltodextrins, specialty sweeteners and various texturizers.